Alpha 2.0
Login Register
» Articles » PMID: 33861524

SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia

Overview
Journal N Engl J Med
Specialty General Medicine
Date 2021 Apr 16
PMID 33861524
Citations 304
Authors
Douglas B Cines
James B Bussel
Affiliations
Soon will be listed here.
Citing Articles

Network analysis of adverse event patterns following immunization with mRNA COVID-19 vaccines: real-world data from the European pharmacovigilance database EudraVigilance.

Ferreira-da-Silva R, Lobo M, Pereira A, Morato M, Polonia J, Ribeiro-Vaz I Front Med (Lausanne). 2025; 12:1501921.

PMID: 40046918 PMC: 11879978. DOI: 10.3389/fmed.2025.1501921.

Immune thrombocytopaenic purpura following the second dose of Pfizer COVID-19 vaccine.

Latef T, Howard L, Loke C, Tsui E BMJ Case Rep. 2025; 15(9).

PMID: 39901382 PMC: 9442476. DOI: 10.1136/bcr-2022-249477.

Adenoviral Vector-Based Vaccine Expressing Hemagglutinin Stem Region with Autophagy-Inducing Peptide Confers Cross-Protection Against Group 1 and 2 Influenza A Viruses.

Wang W, Sayedahmed E, Alhashimi M, Elkashif A, Gairola V, Murala M Vaccines (Basel). 2025; 13(1).

PMID: 39852874 PMC: 11769558. DOI: 10.3390/vaccines13010095.

Distinct response patterns of endothelial markers to the BNT162b2 mRNA COVID-19 booster vaccine are associated with the spike-specific IgG antibody production.

Castro-Robles B, Cimas F, Arias-Salazar L, Ontanon J, Lozano J, Lopez-Lopez S Front Immunol. 2025; 15():1471401.

PMID: 39835131 PMC: 11743620. DOI: 10.3389/fimmu.2024.1471401.

Unraveling Cardiovascular Risks and Benefits of COVID-19 Vaccines: A Systematic Review.

Satyam S, El-Tanani M, Bairy L, Rehman A, Srivastava A, Kenneth J Cardiovasc Toxicol. 2025; 25(2):306-323.

PMID: 39826014 DOI: 10.1007/s12012-024-09954-2.

References
1.
Althaus K, Marini I, Zlamal J, Pelzl L, Singh A, Haberle H . Antibody-induced procoagulant platelets in severe COVID-19 infection. Blood. 2021; 137(8):1061-1071. PMC: 7791311. DOI: 10.1182/blood.2020008762. View
2.
Scully M, Singh D, Lown R, Poles A, Solomon T, Levi M . Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination. N Engl J Med. 2021; 384(23):2202-2211. PMC: 8112532. DOI: 10.1056/NEJMoa2105385. View
3.
Greinacher A, Selleng K, Warkentin T . Autoimmune heparin-induced thrombocytopenia. J Thromb Haemost. 2017; 15(11):2099-2114. DOI: 10.1111/jth.13813. View
4.
Greinacher A, Thiele T, Warkentin T, Weisser K, Kyrle P, Eichinger S . Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination. N Engl J Med. 2021; 384(22):2092-2101. PMC: 8095372. DOI: 10.1056/NEJMoa2104840. View
5.
Schultz N, Sorvoll I, Michelsen A, Munthe L, Lund-Johansen F, Ahlen M . Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination. N Engl J Med. 2021; 384(22):2124-2130. PMC: 8112568. DOI: 10.1056/NEJMoa2104882. View